Latest Breaking News On - Proteovant sciences - Page 1 : comparemela.com

Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update

BASEL, Switzerland and LONDON and NEW YORK, Feb. 13, 2024 Roivant today reported its financial results for the third quarter ended December 31, 2023, and provided a business update. Roivant.

City ofUnited kingdomMatt glineStephanie leeExchange commissionSecurities exchangeNational prescription auditProteovant sciences incRoivant sciences ltdRoivant sciencesDevelopment expensesEczema areaSeverity indexPeak pruritus numeric rating scaleQuarter ended decemberProteovant sciences

SK Biopharm to Expand R&D Capabilities with Acquisition of ProteoVant Sciences

SK Biopharm to Expand R&D Capabilities with Acquisition of ProteoVant Sciences
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

Soult ukpyolsiSouth koreaProteovant sciencesKorea bizwireRoivant science

SK Biopharmaceuticals acquires 60 percent stake in Proteovant Therapeutics at W62b

SK Group’s pharmaceutical arm, SK Biopharmaceuticals, said Friday that it has decided to acquire a 60 percent stake, or 40 million shares, in US biotech company Proteovant Therapeutics for 62 billion won ($47 million). This deal size is equivalent to 19.6 percent of the Korean company’s total equity capital. Established in New York in 2021, Proteovant Sciences is a 60:40 joint venture between Swiss biotec.

New yorkUnited statesRyu ji sooLee dong hoonRoivant sciencesProteovant sciencesSk groupSk bio investment centerProteovant therapeutics